For young women facing chemotherapy as part of a range of treatments for breast cancer, the question of fertility post-treatment is of particular concern. But the results of a phase III clinical trial mean that women might be able to have their cancer treated, and still go on to have children.
Watch the video interview with Dr. Halle Moore
The study, funded by the National Institutes of Health and led by Dr. Halle Moore of the Taussig Cancer Institute in Cleveland, USA, followed 218 premenopausal women suffering breast cancer over an eight-year period. The hormonal therapy goserelin was used to put women into a temporary menopause, and those receiving it were twice as likely to be able to have a baby post-cancer.